Effectiveness and safety of 4-factor prothrombin complex concentrate (4PCC) in neonates with intractable bleeding or severe coagulation disturbances: a retrospective …

G Mitsiakos, M Karametou, A Gkampeta… - Journal of Pediatric …, 2019 - journals.lww.com
Background: To date, clinical experience with prothrombin complex concentrate (PCC) in
the neonatal population has been limited. Aim: The objective of this study was to describe …
被引用次数：7 相关文章

Effectiveness and Safety of 4-factor Prothrombin Complex Concentrate (4PCC) in Neonates With Intractable Bleeding or Severe Coagulation Disturbances: A …

G Mitsiakos, M Karametou, A Gkampeta… - Journal of Pediatric …, 2019 - europepmc.org
Background To date, clinical experience with prothrombin complex concentrate (PCC) in the
neonatal population has been limited. Aim The objective of this study was to describe our …

Effectiveness and Safety of 4-factor Prothrombin Complex Concentrate (4PCC) in Neonates With Intractable Bleeding or Severe Coagulation Disturbances: A …

G Mitsiakos, M Karametou, A Gkampeta… - Journal of Pediatric …, 2019 - ingentaconnect.com
Background: To date, clinical experience with prothrombin complex concentrate (PCC) in
the neonatal population has been limited. Aim: The objective of this study was to describe …

Effectiveness and Safety of 4-factor Prothrombin Complex Concentrate (4PCC) in Neonates With Intractable Bleeding or Severe Coagulation Disturbances: A …

G Mitsiakos, M Karametou… - Journal of pediatric …, 2019 - pubmed.ncbi.nlm.nih.gov
Background To date, clinical experience with prothrombin complex concentrate (PCC) in the
neonatal population has been limited. Aim The objective of this study was to describe our …